By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ophthotech Corporation 

5 Vaughn Drive
Suite 106
Princeton  New Jersey  08540  U.S.A.
Phone: 609-945-6050 Fax: 609-452-7435


SEARCH JOBS








Company News
Ophthotech Corporation (OPHT) Added To NASDAQ Biotechnology Index 12/15/2014 10:28:42 AM
Ophthotech Corporation (OPHT) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/2/2014 2:57:56 PM
Ophthotech Corporation (OPHT) To Present At The Stifel 2014 Healthcare Conference 11/13/2014 10:48:39 AM
Ophthotech Corporation (OPHT) Provides Business Update And Reports Third Quarter 2014 Financial Results 11/11/2014 9:19:28 AM
AVEO Oncology (AVEO), Ophthotech Corporation (OPHT) Forge Research, License Deal Worth $105 Million+ 11/11/2014 7:03:37 AM
Ophthotech Corporation (OPHT) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Tuesday, November 11, 2014 11/3/2014 10:01:59 AM
Ophthotech Corporation (OPHT) Names Todd N. Smith As Chief Commercial Officer 10/3/2014 8:15:34 AM
Ophthotech Corporation (OPHT) Names Michael G. Atieh As Executive Vice President And Chief Financial And Business Officer 9/23/2014 9:49:10 AM
Ophthotech Corporation (OPHT) Announces Fovista® Phase 2b Independent Analysis Shows That Fovista® Anti-PDGF Therapy, Combined With Anti-VEGF Therapy, Is Associated With A Reduction Of Sub-Retinal Fibrosis In Wet AMD Patients 9/16/2014 9:12:28 AM
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014 6:05:20 AM
12345
//-->